Company: DVAX
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001628280-25-049536
Chunk: 215

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 1
Chunk 215
---
240)23,226 Provision for income taxes(1,492)(2,224)(2,211)(2,967)Net income (loss)$26,927 $17,594 $(50,451)$20,259 Net income (loss) per share:    Basic$0.23 $0.13 $(0.42)$0.15 Diluted$0.21 $0.12 $(0.42)$0.15 Weighted-average shares used in computing net income (loss) per share:    Basic117,307 131,133 120,471 130,746 Diluted136,468 154,807 120,471 133,644 

See accompanying notes.

5

Table of Contents

Condensed Consolidated Statements of Comprehensive Income (loss)

(In thousands)

(Unaudited)

 Three Months Ended September 30,Nine Months Ended September 30, 2025202420252024Net income (loss)$26,927 $17,594 $(50,451)$20,259 Other comprehensive income, net of tax:        Change in unrealized gain or loss on marketable securities available-for-sale200 4,021 121 2,275 Cumulative foreign currency translation adjustments(52)1,404 5,401 347 Total other comprehensive income148 5,425 5,522 2,622 Total comprehensive income (loss)$27,075 $23,019 $(44,929)$22,881 

See accompanying notes.

6

Dynavax Technologies Corporation 

Condensed Consolidated Statements of Stockholders’ Equity 

(In thousands) 

(Unaudited) 

 Common Stock Three Months Ended September 30, 2025SharesPar AmountAdditionalPaid-In CapitalAccumulatedOtherComprehensive (Loss) IncomeAccumulated Deficit TotalStockholders' EquityBalances at June 30, 2025117,230$117 $1,474,046 $652 $(980,653)$494,162 Issuance of common stock upon exercise of stock options11-95--95Issuance of common stock upon release of restricted and performance stock awards, net of statutory tax withholdings50-(248)--(248)Issuance of common stock under Employee Stock Purchase Plan73-664--664Repurchase of common stock inclusive of excise tax (Note 11)— —